Form 4 for KMTS KESTRA MEDICAL TECHNOLOGIES, LTD.
Accepted 2026-07-17 17:48:52 ET · period of report 2026-07-15 · accession 0001193125-26-308041 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-07-17 17:48 | 2026-07-15 | KMTS | Webster Brian Daniel | See Remarks, Dir | A - Grant | $0.00 | +176.5K | 571.9K | +45% | $0 |
| MT | 2026-07-17 17:48 | 2026-07-15 | KMTS | Webster Brian Daniel | See Remarks, Dir | S - Sale | $22.44 | -15.0K | 556.9K | -3% | -$336.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2026-07-15 | A | A | 176,470 | $0.00 | 571,937 | D | — | — | (F1) Represents common shares earned with respect to an award of performance-based RSUs ("PSUs") granted on July 17, 2025, as determined based on the Issuer's achievement of specified performance goals. 100% of the PSUs vested on July 15, 2026. |
| 2 | Common | Common Shares | 2026-07-15 | S | D | 11,216 | $22.01 | 560,721 | D | — | — | (F2) The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025. (F3) The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $21.45 to $22.44. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. |
| 3 | Common | Common Shares | 2026-07-15 | S | D | 784 | $22.63 | 559,937 | D | — | — | (F2) The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025. (F4) The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.45 to $23.00. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. |
| 4 | Common | Common Shares | 2026-07-15 | S | D | 3,000 | $24.00 | 556,937 | D | — | — | (F2) The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025. (F5) The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $23.49 to $24.10. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. |